TrialMultiple sclerosis (Houndmills, Basingstoke, England)2026

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

J L Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.